Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Cancer
- Conditions
- Pancreatic Tubular Adenocarcinoma
- Interventions
- Other: Observation
- Registration Number
- NCT00947102
- Lead Sponsor
- Blood Transfusion Centre of Slovenia
- Brief Summary
Observational study of influence of gemcitabine treatment on serological and immunological status and gene expression profile in patients with pancreatic tubular carcinoma after tumor resection.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- ECOG performance status 0-2 at the time of inclusion
- Following R0 or R1 pancreatic tubular adenocarcinoma resection
Exclusion Criteria
- Pregnancy
- Serious comorbidity
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Pancreatic tubular adenocarcinoma Observation Patients with pancreatic tubular adenocarcinoma
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University Medical Centre Ljubljana; Department for Gastroenterology
🇸🇮Ljubljana, Slovenia